期刊文献+

反义基因治疗在卵巢癌中的应用 被引量:2

Application of antisense gene therapy in ovarian carcinoma
下载PDF
导出
摘要 反义基因治疗是通过反义核酸抑制某些异常基因的表达,使肿瘤细胞进入正常分化轨道或导致瘤细胞凋亡。反义药物经大量的体外实验及动物实验被证实在多种疾病的治疗中效果肯定,部分药物已进入了临床试验阶段。反义治疗已在病毒性疾病、寄生虫感染、遗传性疾病尤其是恶性肿瘤的诊治方面显示出广阔的前景。现对反义基因治疗的作用机制、反义药物运输系统以及在卵巢癌治疗方面的研究作简要综述。
出处 《国外医学(肿瘤学分册)》 2005年第10期790-793,共4页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献3

二级参考文献23

  • 1郭惠夫,王晓民,韩济生.反义技术及其在神经科学中的应用[J].生理科学进展,1994,25(4):365-372. 被引量:2
  • 2Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 1997,90:785-795.
  • 3Horikawa I, Cable PL, Afshari C,et al. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res, 1999,59:826-830.
  • 4Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med, 1999, 5:1164-1170.
  • 5Agrawal S. Antisense oligonucleotides: towards clinical trials. Trends Biotechnol, 1996,14:376-387.
  • 6Yokoyama Y, Takahashi Y, Shinohara A, et al. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res, 1998,58:5406-5410.
  • 7Norton JC, Piatyszek MA, Wright WE, et al. Inhibition of human telomerase activity by peptide nucleic acids. Nat Biotechnol, 1996,14:615-619.
  • 8Tao M, Miyano-Kurosaki N, Takai K,et al. Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells. FEBS Lett, 1999,454:312-316.
  • 9Sounni NE,Devy L,Hajitou A,et al.MT1 MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression [J].FASEB J,2002,16(6):555-564.
  • 10Heussen C,Dowdle EB.Electrophoretic analysis of plasminogen activation in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates [J].Anal Biochem,1980,102(1):196-202.

共引文献14

同被引文献42

  • 1双金权,吴婷,庄则豪.反义RNA与胃癌的研究新进展[J].实用癌症杂志,2004,19(4):437-439. 被引量:1
  • 2张娇,刘倩,王杰,毛海婷.FasL反义寡核苷酸逆转肝癌细胞免疫逃逸的实验研究[J].中国现代普通外科进展,2006,9(3):147-150. 被引量:6
  • 3陈乔尔,王元银,李倩,周健.口腔黏膜癌前病变和口腔鳞癌组织Fas/FasL的表达及其意义[J].临床口腔医学杂志,2006,22(7):413-416. 被引量:3
  • 4Yildiz D, Oztas H, Hilal Ares B. Antisense oligonucleotides and prevention of tumor growth: a different approach and proposal for a new method [J]. Med Hypotheses, 2005, 64 (2): 328.
  • 5aTortora G, Caputo R, Fontamm Get al. Combined blockade of protein kinase A and bcl -2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis [J].. Clin Cancer Res, 2001, 7 (8) : 2537.
  • 6Fei R, Shaoyang L. Combination antigene therapy targeting c - myc and c - erbB - 2 in the ovarian cancer COC ( 1 ) cell line[J].GynecolOneol, 2002, 85 (1): 40.
  • 7Corey DR. Telomerrase inhibition, oligonucleotides and clinical trials [J] .Oncogene, 2002, 21 (4): 631.
  • 8Coppola D, Saunders B, Fu L et al. The insulin - like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down -regulates their Fas -receptor expression [J]. Cancer Res, 1999, 59 (13): 3264.
  • 9Bianco C, Bianeo R, Tortora G et al. Antitumor activity of eombined treatment of human cancer cells with ionizing radiation and anti - epidermal growth factor receptor monoclona] antibody (2225 plus type 1 protein kinase A antisense olignnucleotide[J]. Clin Cancer Res, 2000, 6 (11): 4343.
  • 10Neetu D, Cheryl A, Tian L et al. MicroRNA expression and identification of putative miRNA targets in ovarian cancer [ J ]. PLoS ONE, 2008, 3 (6) 1.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部